Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation

(2019) Renato D. Lopes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI

(2019) Davide Capodanno et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

(2019) Renato D. Lopes et al.   JAMA Cardiology

Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis

(2019) Paul M Haller et al.   European Heart Journal-Cardiovascular Pharmacotherapy

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial

(2019) Pascal Vranckx et al.   LANCET

2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA)

(2018) Gregory Y H Lip et al.   EUROPACE

Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials

(2018) Harsh B Golwala et al.   EUROPEAN HEART JOURNAL

2018 ESC/EACTS Guidelines on myocardial revascularization

(2018) Franz-Josef Neumann et al.   EUROPEAN HEART JOURNAL

Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?

(2018) Felice Gragnano et al.   EUROPEAN HEART JOURNAL

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

(2017) Christopher P. Cannon et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Critical Appraisal of Aspirin in Secondary Prevention

(2016) Giuseppe Gargiulo et al.   CIRCULATION

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

(2016) Paulus Kirchhof et al.   EUROPEAN HEART JOURNAL

Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI

(2016) C. Michael Gibson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation

(2015) Katrin A. Fiedler et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

(2013) Willem JM Dewilde et al.   LANCET

Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

(2013) Christian T Ruff et al.   LANCET

Intensifying Platelet Inhibition With Tirofiban in Poor Responders to Aspirin, Clopidogrel, or Both Agents Undergoing Elective Coronary Intervention

(2009) Marco Valgimigli et al.   CIRCULATION

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles

(2009) A. Goette et al.   EUROPEAN HEART JOURNAL

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE